$24.27
0.45[1.89%]
At close: Apr 29
$24.27
0[0.00%]
After Hours: 4:00PM EDT
Doximity Stock (NYSE:DOCS), Analyst Ratings, Price Targets, Predictions
Doximity Inc has a consensus price target of $32.46, established from looking at the 78 latest analyst ratings. The last 3 analyst ratings were released from JP Morgan, Morgan Stanley, and Evercore ISI Group on April 25, 2024, April 23, 2024, and April 2, 2024. With an average price target of $26.67 between JP Morgan, Morgan Stanley, and Evercore ISI Group, there's an implied 9.88% upside for Doximity Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
JP Morgan
Morgan Stanley
Evercore ISI Group
Leerink Partners
Truist Securities
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Doximity
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/25/2024 | DOCS | Buy Now | Doximity | $24.27 | 3.01% | JP Morgan | Anne Samuel | → $25 | Upgrade | Underweight → Neutral | Get Alert |
| 04/23/2024 | DOCS | Buy Now | Doximity | $24.27 | 3.01% | Morgan Stanley | Ricky Goldwasser | $25 → $25 | Maintains | Underweight | Get Alert |
| 04/02/2024 | DOCS | Buy Now | Doximity | $24.27 | 23.61% | Evercore ISI Group | Elizabeth Anderson | → $30 | Maintains | In-Line | Get Alert |
| 03/15/2024 | DOCS | Buy Now | Doximity | $24.27 | 3.01% | JP Morgan | Anne Samuel | $22 → $25 | Maintains | Underweight | Get Alert |
| 02/26/2024 | DOCS | Buy Now | Doximity | $24.27 | 31.85% | Leerink Partners | Michael Cherny | → $32 | Initiates | → Market Perform | Get Alert |
| 02/09/2024 | DOCS | Buy Now | Doximity | $24.27 | 19.49% | Truist Securities | Jailendra Singh | $28 → $29 | Maintains | Hold | Get Alert |
| 02/09/2024 | DOCS | Buy Now | Doximity | $24.27 | 11.25% | Wells Fargo | Stan Berenshteyn | $25 → $27 | Maintains | Equal-Weight | Get Alert |
| 01/23/2024 | DOCS | Buy Now | Doximity | $24.27 | 31.85% | B of A Securities | Allen Lutz | $29 → $32 | Maintains | Neutral | Get Alert |
| 01/02/2024 | DOCS | Buy Now | Doximity | $24.27 | 19.49% | B of A Securities | Allen Lutz | $21 → $29 | Upgrade | Underperform → Neutral | Get Alert |
| 11/10/2023 | DOCS | Buy Now | Doximity | $24.27 | -5.23% | Piper Sandler | Jessica Tassan | $21 → $23 | Maintains | Neutral | Get Alert |
| 11/10/2023 | DOCS | Buy Now | Doximity | $24.27 | 3.01% | Morgan Stanley | Ricky Goldwasser | $21 → $25 | Maintains | Underweight | Get Alert |
| 09/05/2023 | DOCS | Buy Now | Doximity | $24.27 | 35.97% | Canaccord Genuity | Richard Close | $40 → $33 | Maintains | Buy | Get Alert |
| 08/11/2023 | DOCS | Buy Now | Doximity | $24.27 | 3.01% | Wells Fargo | Stan Berenshteyn | $37 → $25 | Maintains | Equal-Weight | Get Alert |
| 08/09/2023 | DOCS | Buy Now | Doximity | $24.27 | 15.37% | Truist Securities | Jailendra Singh | $33 → $28 | Maintains | Hold | Get Alert |
| 08/09/2023 | DOCS | Buy Now | Doximity | $24.27 | -13.47% | Morgan Stanley | Ricky Goldwasser | $28 → $21 | Maintains | Underweight | Get Alert |
| 08/09/2023 | DOCS | Buy Now | Doximity | $24.27 | — | Guggenheim | Sandy Draper | — | Downgrade | Buy → Neutral | Get Alert |
| 08/09/2023 | DOCS | Buy Now | Doximity | $24.27 | 23.61% | Raymond James | Brian Peterson | $40 → $30 | Maintains | Outperform | Get Alert |
| 08/09/2023 | DOCS | Buy Now | Doximity | $24.27 | — | Needham | Scott Berg | — | Downgrade | Buy → Hold | Get Alert |
| 08/03/2023 | DOCS | Buy Now | Doximity | $24.27 | 48.33% | Piper Sandler | Jessica Tassan | $38 → $36 | Downgrade | Overweight → Neutral | Get Alert |
FAQ
What is the target price for Doximity (DOCS)?
The latest price target for Doximity (NYSE: DOCS) was reported by JP Morgan on April 25, 2024. The analyst firm set a price target for $25.00 expecting DOCS to rise to within 12 months (a possible 3.01% upside). 27 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Doximity (DOCS)?
The latest analyst rating for Doximity (NYSE: DOCS) was provided by JP Morgan, and Doximity upgraded their neutral rating.
When was the last upgrade for Doximity (DOCS)?
The last upgrade for Doximity Inc happened on April 25, 2024 when JP Morgan raised their price target to $25. JP Morgan previously had an underweight for Doximity Inc.
When was the last downgrade for Doximity (DOCS)?
The last downgrade for Doximity Inc happened on August 9, 2023 when Guggenheim changed their price target from N/A to N/A for Doximity Inc.
When is the next analyst rating going to be posted or updated for Doximity (DOCS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Doximity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Doximity was filed on April 25, 2024 so you should expect the next rating to be made available sometime around April 25, 2025.
Is the Analyst Rating Doximity (DOCS) correct?
While ratings are subjective and will change, the latest Doximity (DOCS) rating was a upgraded with a price target of $0.00 to $25.00. The current price Doximity (DOCS) is trading at is $24.27, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.